This section is not available in the published analysis.
CureVac: Audience
CureVac is a clinical-stage biopharmaceutical company specializing in the development of mRNA technology for medical applications. The company focuses on creating innovative treatments that enable the body to produce its own prophylactic and therapeutic medications.